Literature DB >> 31523965

Functional Rescue of Cataract-Causing αA-G98R-Crystallin by Targeted Compensatory Suppressor Mutations in Human αA-Crystallin.

Ashutosh S Phadte1,2, Sundararajan Mahalingam1, Puttur Santhoshkumar1, Krishna K Sharma1,2.   

Abstract

The G98R mutation in αA-crystallin is associated with the onset of presenile cataract and is characterized biochemically by an increased oligomeric mass, altered chaperone function, and loss of structural stability over time. Thus, far, it is not known whether the inherent instability caused by gain-of-charge mutation could be rescued by a compensatory loss of charge mutation elsewhere on the protein. To answer this question, we investigated whether αA-G98R-mediated instability could be rescued through suppressor mutations by introducing site-specific "compensatory" mutations in αA-G98R-crystallin, αA-R21Q/G98R, αA-G98R/R116C, and αA-R157Q/G98R. The recombinant proteins were expressed, purified, characterized, and evaluated by circular dichroism (CD), intrinsic fluorescence, and bis-ANS-binding studies. Chaperone-like activities of recombinant proteins were assessed using alcohol dehydrogenase (ADH) and insulin as unfolding substrates. Far-UV CD studies revealed an increased α-helical content in αA-G98R in comparison to αA-WT, αA-R21Q, R157Q, and the double mutants, αA-R21Q/G98R, and αA-R157Q/G98R. Compared to αA-WT, αA-R21Q, and αA-G98R, the double mutants showed an increased intrinsic tryptophan fluorescence, whereas the highest hydrophobicity (bis-ANS-binding) was shown by αA-G98R. Introduction of a second mutation in αA-G98R reduced its bis-ANS-binding activity. Both αA-R21Q/G98R and αA-R157Q/G98R showed greater chaperone-like activity against ADH aggregation than αA-G98R. However, among the three G98R mutants, only αA-R21Q/G98R protected ARPE-19 cells from H2O2-induced cytotoxicity. These results suggest that the lost chaperone-like activity of αA-G98R-crystallin can be rescued by another targeted mutation and that substitution of αA-R21Q-crystallin at the N-terminal region can rescue a deleterious mutation in the conserved α-crystallin domain of the protein.

Entities:  

Year:  2019        PMID: 31523965      PMCID: PMC7266266          DOI: 10.1021/acs.biochem.9b00374

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  53 in total

1.  Characterization of alpha-crystallin-plasma membrane binding.

Authors:  B A Cobb; J M Petrash
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 2.  Alpha-crystallin.

Authors:  Joseph Horwitz
Journal:  Exp Eye Res       Date:  2003-02       Impact factor: 3.467

3.  Unfolding and refolding of bovine alpha-crystallin in urea and its chaperone activity.

Authors:  S Saha; K P Das
Journal:  Protein J       Date:  2007-08       Impact factor: 2.371

4.  Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20.

Authors:  C Bagnéris; O A Bateman; C E Naylor; N Cronin; W C Boelens; N H Keep; C Slingsby
Journal:  J Mol Biol       Date:  2009-07-30       Impact factor: 5.469

5.  Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR.

Authors:  Lihua He; Luba A Aleksandrov; Liying Cui; Timothy J Jensen; Kenneth L Nesbitt; John R Riordan
Journal:  FASEB J       Date:  2010-03-16       Impact factor: 5.191

6.  Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking.

Authors:  M L Plater; D Goode; M J Crabbe
Journal:  Ophthalmic Res       Date:  1997       Impact factor: 2.892

7.  Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations.

Authors:  R K Brachmann; K Yu; Y Eby; N P Pavletich; J D Boeke
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

8.  An alphaA-crystallin gene mutation, Arg12Cys, causing inherited cataract-microcornea exhibits an altered heat-shock response.

Authors:  Li-Yun Zhang; Gary Hin-Fai Yam; Pancy Oi-Sin Tam; Ricky Yiu-Kwong Lai; Dennis Shun-Chiu Lam; Chi-Pui Pang; Dorothy Shu-Ping Fan
Journal:  Mol Vis       Date:  2009-06-04       Impact factor: 2.367

9.  Enhancement of chaperone function of alpha-crystallin by methylglyoxal modification.

Authors:  Ram H Nagaraj; Tomoko Oya-Ito; Pius S Padayatti; Radhika Kumar; Sachin Mehta; Karen West; Bruce Levison; Jian Sun; John W Crabb; Anoop K Padival
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

10.  The eye lens chaperone alpha-crystallin forms defined globular assemblies.

Authors:  Jirka Peschek; Nathalie Braun; Titus M Franzmann; Yannis Georgalis; Martin Haslbeck; Sevil Weinkauf; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

View more
  4 in total

Review 1.  α-Crystallins in the Vertebrate Eye Lens: Complex Oligomers and Molecular Chaperones.

Authors:  Marc A Sprague-Piercy; Megan A Rocha; Ashley O Kwok; Rachel W Martin
Journal:  Annu Rev Phys Chem       Date:  2020-12-15       Impact factor: 12.703

2.  Deletion of Specific Conserved Motifs from the N-Terminal Domain of αB-Crystallin Results in the Activation of Chaperone Functions.

Authors:  Sundararajan Mahalingam; Goutham Shankar; Brian P Mooney; Kamal Singh; Puttur Santhoshkumar; Krishna K Sharma
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

3.  Substrate Protein Interactions and Methylglyoxal Modifications Reduce the Aggregation Propensity of Human Alpha-A-Crystallin G98R Mutant.

Authors:  Puttur Santhoshkumar; Krishna K Sharma
Journal:  Front Mol Biosci       Date:  2022-04-06

Review 4.  Therapeutic Potential of α-Crystallins in Retinal Neurodegenerative Diseases.

Authors:  Ashutosh S Phadte; Zachary B Sluzala; Patrice E Fort
Journal:  Antioxidants (Basel)       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.